Clint recently had the opportunity to chat with Rob MacNaughton, the CEO of Calibrate, about the groundbreaking approach his company is taking in the weight loss industry by combining powerful GLP1 drugs like Wegovy and Ozempic with clinicianled lifestyle interventions. Rob shares insights into the advantages and disadvantages of these medications, the impressive results Calibrate has achieved, and the importance of addressing the root causes of obesity. We also delve into Rob's diverse background, the challenges and benefits of leading a fully remote company, and the role of AI in enhancing member experience and operational efficiency.

Timestamps:
00:00 Introduction
00:09 Rob's background and the rise of GLP1 drugs
01:03 Calibrate's unique approach to weight loss
02:29 Impressive results and published data
04:00 Safety and efficacy of GLP1 drugs
05:14 What a typical week looks like for Calibrate members
07:19 Rob's journey to Calibrate
12:36 The importance of addressing the root cause of obesity
14:25 A day in the life of a remote CEO
16:35 Leadership in a remote environment
19:39 Talent acquisition in a remote setting
23:00 The role of AI in Calibrate's operations
26:03 Longterm planning with AI
27:10 The importance of giving and taking chances